Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

8.42
Delayed Data
As of Aug 18
 +0.44 / +5.51%
Today’s Change
2.02
Today|||52-Week Range
9.51
+129.43%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 11.50, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a +36.58% increase from the last price of 8.42.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.12
Sales
$750.0K
Reporting Date
Aug 16

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 77.58%
 
 
 
 
 
 
Growthannually -73.12%
 
 
 
 
 
 

Sales

Growthquarterly -43.33%
 
 
 
 
 
 
Growthannually 47.43%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.